Report Detail
Global Hospital-Acquired Pneumonia (HAP) Drugs Market Research Report 2019
- RnM3123395 |
- 14 March, 2019 |
- Global |
- 94 Pages |
- QYResearch |
- Pharma & Healthcare
HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects the microscopic air sacs called alveoli. This is primarily caused by infection by bacteria or viruses and sometimes with other microorganisms. It can be mainly distinguished on how the infection was acquired.
One trend in the market is combination therapy for the treatment of HAP. Monotherapy is the common treatment given for nosocomial pneumonia. However, combination therapy has sometimes been found to be more appropriate and desirable treatment.
One driver in the market is unmet demand due to lack of available treatment for MDR microorganisms. Lack of proper treatment options available for the treatment of HAP because of MDR microorganisms is a major challenge for the healthcare providers. MDR microorganisms are those microorganisms that have developed antimicrobial drugs resistance. The resistance among various microorganisms to various antimicrobial drugs has emerged as a serious threat to public health across the globe.
The global Hospital-Acquired Pneumonia (HAP) Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hospital-Acquired Pneumonia (HAP) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hospital-Acquired Pneumonia (HAP) Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
Merck
Mylan
Novartis
Teva Pharmaceutical Industries
AstraZeneca
Shinogi
Sun Pharmaceutical Industries
The Medicines Company
Theravance Biopharma
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Antibacterial
Antiviral
Antifungal
Segment by Application
Hospitals
Clinics
Others
Table of Contents
Executive Summary
1 Hospital-Acquired Pneumonia (HAP) Drugs Market Overview
- 1.1 Product Overview and Scope of Hospital-Acquired Pneumonia (HAP) Drugs
- 1.2 Hospital-Acquired Pneumonia (HAP) Drugs Segment by Type
- 1.2.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Antibacterial
- 1.2.3 Antiviral
- 1.2.4 Antifungal
- 1.3 Hospital-Acquired Pneumonia (HAP) Drugs Segment by Application
- 1.3.1 Hospital-Acquired Pneumonia (HAP) Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Others
- 1.4 Global Hospital-Acquired Pneumonia (HAP) Drugs Market by Region
- 1.4.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Size
- 1.5.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Revenue (2014-2025)
- 1.5.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Production (2014-2025)
2 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Competition by Manufacturers
- 2.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Hospital-Acquired Pneumonia (HAP) Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Hospital-Acquired Pneumonia (HAP) Drugs Production Sites, Area Served, Product Types
- 2.5 Hospital-Acquired Pneumonia (HAP) Drugs Market Competitive Situation and Trends
- 2.5.1 Hospital-Acquired Pneumonia (HAP) Drugs Market Concentration Rate
- 2.5.2 Hospital-Acquired Pneumonia (HAP) Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Market Share by Regions
- 3.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Market Share by Regions
- 3.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Hospital-Acquired Pneumonia (HAP) Drugs Production
- 3.4.1 North America Hospital-Acquired Pneumonia (HAP) Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Hospital-Acquired Pneumonia (HAP) Drugs Production
- 3.5.1 Europe Hospital-Acquired Pneumonia (HAP) Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Hospital-Acquired Pneumonia (HAP) Drugs Production (2014-2019)
- 3.6.1 China Hospital-Acquired Pneumonia (HAP) Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Hospital-Acquired Pneumonia (HAP) Drugs Production (2014-2019)
- 3.7.1 Japan Hospital-Acquired Pneumonia (HAP) Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption by Regions
- 4.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption by Regions
- 4.2 North America Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2014-2019)
- 4.3 Europe Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2014-2019)
- 4.4 China Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2014-2019)
- 4.5 Japan Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2014-2019)
5 Global Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Hospital-Acquired Pneumonia (HAP) Drugs Price by Type (2014-2019)
- 5.4 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Growth by Type (2014-2019)
6 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Analysis by Applications
- 6.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Hospital-Acquired Pneumonia (HAP) Drugs Business
- 7.1 Pfizer
- 7.1.1 Pfizer Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.1.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.1.3 Pfizer Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Merck
- 7.2.1 Merck Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.2.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.2.3 Merck Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Mylan
- 7.3.1 Mylan Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.3.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.3.3 Mylan Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Novartis
- 7.4.1 Novartis Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.4.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.4.3 Novartis Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Teva Pharmaceutical Industries
- 7.5.1 Teva Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.5.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.5.3 Teva Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 AstraZeneca
- 7.6.1 AstraZeneca Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.6.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.6.3 AstraZeneca Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Shinogi
- 7.7.1 Shinogi Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.7.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.7.3 Shinogi Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Sun Pharmaceutical Industries
- 7.8.1 Sun Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.8.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.8.3 Sun Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 The Medicines Company
- 7.9.1 The Medicines Company Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.9.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.9.3 The Medicines Company Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Theravance Biopharma
- 7.10.1 Theravance Biopharma Hospital-Acquired Pneumonia (HAP) Drugs Production Sites and Area Served
- 7.10.2 Hospital-Acquired Pneumonia (HAP) Drugs Product Introduction, Application and Specification
- 7.10.3 Theravance Biopharma Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
8 Hospital-Acquired Pneumonia (HAP) Drugs Manufacturing Cost Analysis
- 8.1 Hospital-Acquired Pneumonia (HAP) Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Hospital-Acquired Pneumonia (HAP) Drugs
- 8.4 Hospital-Acquired Pneumonia (HAP) Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Hospital-Acquired Pneumonia (HAP) Drugs Distributors List
- 9.3 Hospital-Acquired Pneumonia (HAP) Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Forecast
- 11.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue Forecast
- 11.1.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Hospital-Acquired Pneumonia (HAP) Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2019-2025)
- 11.4 Global Hospital-Acquired Pneumonia (HAP) Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Hospital-Acquired Pneumonia (HAP) Drugs . Industry analysis & Market Report on Hospital-Acquired Pneumonia (HAP) Drugs is a syndicated market report, published as Global Hospital-Acquired Pneumonia (HAP) Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Hospital-Acquired Pneumonia (HAP) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
